MIRA INFORM REPORT

 

 

Report Date :

26.06.2013

 

IDENTIFICATION DETAILS

 

Name :

RECKITT BENCKISER HEALTHCARE INDIA LIMITED (w.e.f.12.06.2012)

 

 

Formerly Known As :

PARAS PHARMACEUTICALS LIMITED

 

 

Registered Office :

Plot No. 48, Institutional Area, Sector-32, Gurgaon-122001, Haryana

 

 

Country :

India

 

 

Financials (as on) :

31.12.2011 (Profit and Loss Account)

 

 

Date of Incorporation :

27.11.1980

 

 

Com. Reg. No.:

05-044172

 

 

Capital Investment / Paid-up Capital :

Rs.90.515 Millions

 

 

CIN No.:

[Company Identification No.]

U24231HR1980PLC044172

 

 

PAN No.:

[Permanent Account No.]

AAACP9268J

 

 

Legal Form :

A Closely held Public Limited Liability Company.

 

 

Line of Business :

Manufacturing of Pharmaceutical Products and Bulk Drugs.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (60)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 5000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established company having fair track record. As per the available financials i.e. profit and loss statement for the 9 months period ranging from April 1, 2011 to December 31 , 2011. The performance of the company appears to be good. Trade relations are fair. Business is active. Payment terms are reported as regular and as per commitments.

 

In view of experienced promoters and reputed holding company, the company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION DENIED

 

Not able to contact the company on the available number.

(Tel. No.: 91-124-4028000 / 3319000)

 

 

LOCATIONS

 

Registered Office :

Plot No. 48, Institutional Area, Sector – 32, Gurgaon – 122001, Haryana, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

skshah@paraspharma.com

admin@paraspharma.com

paras@gnahd.paras.globalnet.in

export@paraspharma.com

parasglobal@gmail.com

sarita.william@rb.com

manoj.bisht@rb.com

legal.india@rb.com

Website :

http://www.paraspharma.com

 

 

Corporate Office :

“Paras House”, 6-B, Sattar Taluka Society, Near Navjinva Press, Ashram Road, Ahmedabad-380014, Gujarat, India

Tel. No.:

91-79-27544475/ 27544484

Fax No.:

91-79-27544485

 

 

Factory.1 :

Plot 1/7, GIDC Estate, Kalol, District Mehsana, Gujarat, India

 

 

Factory.2:

701, 534, Baddi Nalagarh Road, Post Office Baddi, Village Sandholi, Baddi-173205, Himachal Pradesh, India

Tel. No.:

91-1795-245572 / 245573

 

 

DIRECTORS

 

As on 30.06.2012

 

Name :

Mr. Chander Mohan Sethi

Designation :

Additional Director

Address :

302-B, Court Greens, Laburnum Condominium Complex, Sushant Lok-I, Gurgaon-122002, Haryana, India

Date of Birth/Age :

08.03.1949

Qualification :

MBA

Date of Appointment :

11.04.2011

DIN No.:

00319297

 

 

Name :

Mr. Parag Agarwal

Designation :

Additional Director

Address :

Apartment 1B, Tower TG-6, Orchid Garden, Sun City, Sector-54, Gurgaon-122002, Haryana, India

Date of Birth/Age :

19.02.1966

Qualification :

CA

Date of Appointment :

11.04.2011

DIN No.:

02954487

 

 

Name :

Mr. Jose Joaquin Camero Gonzalez

Designation :

Director

Address :

Barnet Desclot, 18 Casa 08190, Santcugal, Barcelona 08190 Spain

Date of Birth/Age :

01.08.1955

Qualification :

MBA, MS Finance, Georgia Institute of Technology and GA State U

Date of Appointment :

11.04.2011

DIN No.:

02466459

 

 

Name :

Mr. Rajesh Kumar Jha

Designation :

Alternate director

Address :

C-3, 3164, Vasant Kunj, New Delhi-110019, India

Date of Birth/Age :

30.06.1968

Qualification :

LLB

Date of Appointment :

16.08.2011

DIN No.:

02695721

 

 

Name :

Mr. Roopak Sushil Taneja

Designation :

Director

Address :

C/o Reckit Benckiser P.O. Box 61344 Dubai, United Arab Emirates

Date of Birth/Age :

24.01.1967

Qualification :

CA

Date of Appointment :

11.04.2011

DIN No.:

02889984

 

 

KEY EXECUTIVES

 

Name :

Mr. Sthitapranga Kantilal Shah

Designation :

Secretary

Address :

2/2, Mrudul Park Society, Dr. V.S. Road, Ahmedabad-380015, Gujarat, India

Date of Birth/Age :

21.12.1961

Date of Appointment :

01.03.2000

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.06.2012

 

Names of Shareholders

 

 

No. of Shares

Reekitt Benckiser Investment India Private Limited, Singapore

 

9090900

R and C Nominees Limited, Berkshire

 

10

Chander Mohan Sethi

 

1

Parag Agarwal

 

1

Savamoy Roy Chowdhary

 

1

Ajay Thukral

 

1

Rajesh Kumar Jha

 

1

Sarita William

 

1

TOTAL

 

9090916

 

As on 30.06.2012

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Bodies corporate

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Pharmaceutical Products and Bulk Drugs.

 

 

Products :

ITC Code No

 

Product Description

33059090

Livon Potion

30049011

Moov Ointment

 

PRODUCTION STATUS [AS ON 31.03.2011]

 

Particulars

Unit

Installed Capacity

Actual Production

Ointment/ Cream

M. Ton

3000

2038

Powder

M. Ton

1800

1769

Liquid

000 Liters

5400

827

Tablets

Million

810

209

 

NOTES:

 

a)       Licensed Capacity not being applicable has not been indicated.

b)       Installed capacity has been certified by the company, this being a technical matter.

c)       Quantity in metric tones unless otherwise stated. Quantity for tables and liquid stated in millions and ‘000 liters respectively.

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

·         Industrial Development Bank of India Limited, IDBI Tower, WTC Complex, Cuffe Parade, Mumbai – 400005, Maharashtra, India

 

·         IDBI Bank Limited,  IDBI Complex, Opposite Municipal Staff Quarters, Near Lal Bunglow, Off C G Road, Ahmedabad-380006, Gujarat, India

 

·         The Kapol Nagrik Sahakari Bank Limited

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S R Batliboi and Associates

Chartered Accountant

Address:

2nd Floor, Shivalik Ishaan, Near C.N. Vidhyalaya, Ambawadi, Ahmedabad, Gujarat, India

Tel. No. :

91-79-66083800

Fax No. :

91-79-66083900

 

 

Subsidiaries:

·         Needwise Advertising Private Limited

      CIN No.: U74300GJ1997PTC032021

·         Paras Overseas Holding Limited (UAE)

·         Paras Inc (USA)

 

 

Step – down Subsidiary Company :

·         Paras Global FZE (UAE) 

·         Paras [Bangladesh] Private Limited

 

 

Associates :

·         Sterling Addlife India Limited (upto 07.10.2010)

CIN No.: U85110GJ2000PLC039121

 

 

Enterprises which exercise significant influence on the company :

·         Actis Advisors Private Limited

·         Actis Consumer India Limited

·         Actis Consumer South Asia Limited

·         Actis Consumer (AEM3A) Limited

·         Actis Consumer (AEM General) Limited

·         Actis Consumer (A13A) Limited

·         Actis Investments Holdings No.80 Limited, Mauritius

 

 

Company in which Directors are Interested :

Viral Industries Private Limited

 

 

CAPITAL STRUCTURE

 

As on 30.06.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35000000

Equity Shares

Rs.10/- each

Rs.350.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9090916

Equity Shares

Rs.10/- each

Rs.90.909 Millions

 

 

 

 

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

25000000

Equity Shares

Rs.10/- each

Rs.250.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

9051522

Equity Shares

Rs.10/- each

Rs.90.515 Millions

 

 

 

 

 

 

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

90.515

90.515

2] Share Application Money

 

0.000

0.000

3] Reserves & Surplus

 

1284.259

1517.074

4] (Accumulated Losses)

 

0.000

0.000

NETWORTH

 

1374.774

1607.589

LOAN FUNDS

 

 

 

1] Secured Loans

 

0.000

0.000

2] Unsecured Loans

 

0.000

0.000

TOTAL BORROWING

 

0.000

0.000

DEFERRED TAX LIABILITIES

 

2.593

22.760

 

 

 

 

TOTAL

 

1377.367

1630.349

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

716.019

846.861

Capital work-in-progress

 

13.593

6.539

 

 

 

 

INVESTMENT

 

481.714

479.323

DEFERREX TAX ASSETS

 

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
356.481
356.844

 

Sundry Debtors

 
120.883
178.546

 

Cash & Bank Balances

 
88.381
189.797

 

Other Current Assets

 
0.000
0.000

 

Loans & Advances

 
157.779
39.719

Total Current Assets

 
723.524
764.906

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
356.079
325.395

 

Other Current Liabilities

 
80.275
65.061

 

Provisions

 
121.129
76.824

Total Current Liabilities

 
557.483
467.280

Net Current Assets

 
166.041
297.626

 

 

 

 

MISCELLANEOUS EXPENSES

 

0.000

0.000

 

 

 

 

TOTAL

 

1377.367

1630.349

 

Note: Balance Sheet of 31.12.2011 (9 Months) is not available only profit and loss account is available.


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.12.2011

(9 Months)

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

3806.686

4670.548

3804.516

 

 

Other Income

90.738

149.085

45.050

 

 

TOTAL                                     (A)

3897.424

4819.633

3849.566

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

737.668

938.399

 

 

 

Purchases of stock-in-trade

668.530

759.236

 

 

 

Employee benefit expense

211.419

297.590

 

 

 

Other expenses

1298.448

1458.441

 

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

186.933

(28.547)

 

 

 

Exceptional items

138.346

0.000

 

 

 

TOTAL                                     (B)

3241.344

3425.119

2794.777

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

656.080

1394.514

1054.789

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.574

1.200

2.815

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

655.506

1393.314

1051.974

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

90.802

125.617

115.599

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

564.704

1267.697

936.375

 

 

 

 

 

Less

TAX                                                                  (H)

209.481

258.343

223.380

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

355.223

1009.354

712.995

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

66.002

85.056

87.450

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Interim Dividend

NA

799.249

543.091

 

 

Proposed Final Dividend

NA

0.000

0.000

 

 

Tax on Dividend

NA

132.745

92.298

 

 

Transfer to General Reserve

NA

102.500

80.000

 

BALANCE CARRIED TO THE B/S

NA

66.002

85.056

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

NA

219.892

133.639

 

TOTAL EARNINGS

NA

219.892

133.639

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Packing  / Raw Materials

NA

NA

7.846

 

 

Capital Goods

NA

NA

10.223

 

TOTAL IMPORTS

NA

NA

18.069

 

 

 

 

 

 

Earnings Per Share (Rs.)

38.46

111.51

78.77

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2011

(9 Months)

31.03.2011

31.03.2010

PAT / Total Income

(%)

9.11
20.94

18.52

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

14.83

27.14

24.61

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

88.06

58.10

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.92

0.58

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

NA

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

NA

1.30

1.64

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

NOTE:

 

The Registered Office of the company has been shifted from Paras House 6-B Sattar Taluka Society NR. Navjivan Press Ashram Road Ahmadabad – 380014, Gujarat India to the present address w.e.f.25.08.2011

 

 

NATURE OF OPERATION:

 

Subject is a fast moving consumer goods [FMCG] Company having household brands in the healthcare and personal care categories.

 

 

WEBSITE DETAILS

 

PRESS RELEASE

 

RB INDIA SCORES HIGH ON MOST TRUSTED BRANDS LIST 2012

 

13.11.2012

Dettol has come in at an admirable number 5 in the top 100 of the Brand Equity Most Trusted Brands List 2012, reports the Economic Times in India.


The survey, conducted by Nielsen on 8160 respondents spread over 12 cities of India, put the RB Powerbrand in the top 5 of the prestigious countdown.


RB brand Moov also makes a showing in the top 100, entering the spotlight at 32 and gaining 14 places up the rankings from last year. Moov continues to be the number 1 trusted painkiller and number 2 trusted OTC brand in the country.


A further six RB India Healthcare brands (Moov #2, Dermicool #9, D'Cold #12, Disprin #13, ItchGuard #14 and Krack #15) feature among the Top 15 OTC brands of the country.

 

 

RB BUYS INDIA’S PARAS PHARMACEUTICALS LIMITED

 

13/12/2010

Reckitt Benckiser Group plc (RB) today announces that it has agreed to buy Paras Pharmaceuticals Limited (Paras) forINR 32.6 billion (Indian Rupees) (approximately GBP 460 million) from the current shareholders, including the Patel family and Actis, the emerging markets private equity investor. RB will finance the transaction from existing facilities.


Paras is a privately-owned Indian company with a portfolio of leading Indian over the counter Health and Personal Care brands including:

 

Moov, the No 2 topical analgesic pain ointment,

D’Cold, the No 2 cold & flu remedy,

Dermicool, the No 2 for prickly heat,

Krack, the No 1 medicated skin treatment for cracked heels and

Itch Guard and Ring Guard anti fungal creams.


In addition, Paras has a personal care business led by Set Wet, a leading hair gel and deodorant brand.

In the fiscal year ending March 2010, Paras generated net sales of INR 4,014 million, representing a mid-teens average growth rate over the last four years, and operating EBITDA for the same year of INR 1,083 million (approximately GBP 56 million and GBP 15 million respectively).


The company has a brand new state of the art and GMP compliant manufacturing plant located at Baddi in Northern India, which employs around 700 people.


Commenting on the acquisition, Reckitt Benckiser CEO, Bart Becht, says, “The acquisition of Paras is another step forward in RB’s growth strategy in consumer health care. It creates a material health care business in India, one of the most promising health care markets in the world with the addition of a number of strong and leading brands.”

“We believe the Paras business has not only extremely good growth potential, when supported by RB’s investment and innovation strength, we also expect to realize material synergies as a result of the integration of Paras into Reckitt Benckiser.”


“The growth potential of the business, the creation of a material health care business in India’s large and growing health care market and the global synergies available make Paras an exciting addition to our portfolio and attractive opportunity for our shareholders.”


RB was advised by JPMorgan. Actis and the other Paras shareholders were advised by Morgan Stanley.

 

 

 

FIXED ASSETS:

 

·         Leasehold Land

·         Freehold Land

·         Building

·         Plant and Machinery

·         Furniture fixture and Fitting

·         Computer Hardware

·         Vehicles

 

Intangible Assets

·         Software 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government:

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package:

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report:

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.70

UK Pound

1

Rs.92.25

Euro

1

Rs.78.38

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

7

--RESERVES

1~10

6

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

60

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.